CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Overnight Digest: Stocks to watch out on June 28
DSIJ Intelligence
/ Categories: Trending, DSIJ News

Overnight Digest: Stocks to watch out on June 28

The stocks to watch out on June 28 include SpiceJet, SunPharma, BHEL, Prism Johnson and Max India

SpiceJet Ltd.: SpiceJet has introduced a direct daily flight connecting Mumbai and Hong-Kong.

Sun Pharmaceutical Industries Ltd.: The company enters into a license agreement with China Medical System Holdings to develop and commercialise Cyclosporine A 0.09% (CsA) eye drops used to treat dry eye disease and Tildrakizumab which is a biological product for treating psoriasis and psoriatic arthritis.

Bharat Heavy Electricals (BHEL):  National Mineral Development Corporation (NMDC) issues a termination notice to the company as it has not been able to complete a Rs 1,395 crore contract awarded in 2011. The completion date of the work was February 28, 2014.

Prism Johnson: Board of Directors of the company at their meeting to be held on July 5, 2019 will consider raising funds through issue of Unsecured, Rated, Listed, Non-convertible Debentures, on private placement basis.

Max India: The company received approval for divestment of entire equity shareholding equivalent to 85.17 per cent of Pharmax's total issued and paid-up equity share capital in its material subsidiary viz. Pharmax Corporation (Pharmax)  to Max Estates, a wholly-owned subsidiary of Max Ventures and Industries for an aggregate consideration of Rs. 61.2 crore.

Previous Article Sentiment Indicators
Next Article Spice Jet launches non-stop flight to Hong Kong
Print
1496 Rate this article:
3.3
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR